期刊文献+

新诊断2型糖尿病短期胰岛素强化治疗前后氧化应激状态变化的观察

IN OXIDACTIVE STRESS AFTER TREATMENT AND THE CHANGS RELATED FACTORS.TYPE 2 DIABETIC PAITIENTS BY SHORT-TERM INSULIN PUMP THERAPY
下载PDF
导出
摘要 目的:通过对2型糖尿病患者短期胰岛素强化治疗,观察治疗前后氧化应激相关因子的变化情况。方法:选择初次诊断2型糖尿病以及病程小于5年的2型糖尿病各30例,给予2周的胰岛素强化治疗(采用胰岛素每日多次皮下注射(MDI)和持续性皮下胰岛素输注(CSII)治疗)。比较治疗前后抽取空腹静脉血测hs-CRP、Hcy、SOD、MDA、MMP-9。结果:胰岛素强化治疗后,病程小于5年组治疗后血清hs-CRP、Hcy、MDA、MMP-9较治疗前下降,SOD升高,初诊组治疗前后上述指标差值则较病程小于5年组显著。结论:胰岛素强化治疗可显著改善氧化应激状态,提示尽早应用胰岛素短期强化治疗可能在2型糖尿病B细胞功能保护及延缓其并发症的发生发展上起到了一定的作用。 Objective:In Type 2 diabetic patients by short-term insulin pump therapy,Oxidative stress before and after treatment and the changes of related factors were studied.Methods: Select the initial diagnosis of type 2 diabetes and duration of less than 5 years 30 cases of type 2 diabetes.Given 2 weeks of intensive insulin therapy(Using multiple daily subcutaneous injection of insulin(MDI) and continuous subcutaneous insulin infusion(CSII) therapy).Fasting venous blood before and after treatment measured hs-CRP、Hcy、SOD、MDA、MMP-9.Results: Intensive insulin treatment,duration of less than 5 years group the serum hs-CRP、Hcy、MDA、MMP-9.compared with before treatment,SOD increased,Diagnosis group before and after treatment than the duration of the index difference is significantly less than 5 years.Conclusion: Intensive insulin therapy can significantly improve the oxidative stress,as soon as possible short-term intensive insulin therapy in type 2 diabetes and delay the development of complications played a certain role.
出处 《牡丹江医学院学报》 2010年第5期21-23,共3页 Journal of Mudanjiang Medical University
基金 黑龙江省卫生厅科研项目(2005-114)
关键词 胰岛素 强化治疗 2型糖尿病 氧化应激 Berberine Type 2 diabetes Mellitus(2-DM) Oxidative stress blood glucose blood lipid
  • 相关文献

参考文献7

二级参考文献18

  • 1马雪松,刘淑文,周坤.胰岛素泵治疗2型糖尿病的临床观察[J].牡丹江医学院学报,2006,27(4):24-25. 被引量:3
  • 2Pan X R,Diabetes Care,1997年,20卷,537页
  • 3陈灏珠.一起由酸败油脂引起的食物中毒[J].实用内科学[M]第11版[M].北京:人民卫生出版社,2001.917-919.
  • 4Wainstein J,Cohen Y,Gilad R,et al.Treatment of severe insulin resistance in type 2 diabetes with insulin pump[J].Diabetologia,2000,43(Suppl 1):789
  • 5Pickup JC, Crouk MA. Is type 2 diabets Mellitus a disease of the innate immue system? Diabetologia 1998;41 : 1241 - 1248.
  • 6Pickup JC, Mattock MB, Chusney GD, et al. NIDDM as a disease of the innate immune system : association of acute phase reactants and interleukin - 6 with metabolic syndrome X. Diabetologia 1997;40:1286 - 1292.
  • 7Freeman DJ, Norrie J, Caslake MJ, et al. C - reactive protein is an independent predietor of risk for the development of diabetes in the west of Scotland oronary Prevention Study. Diabetes 2002 ; 51 : 1131- 1137.
  • 8Andreas F, Ralph D A, Russell P T, et al. Elevated levels of acute phase proteins and plasminogen aetiveator inhibitor- 1 predict the development of type 2 diabetes: The Insulin Resistance Atherosclerosis Study[J]. Diabetes 2002;51 : 1131 - 1137.
  • 9CaliskanS. Hacibekiroglu M, Sever L et. al. Urinary N - acely -beta - D - glueosaminidase and beta 2 - microglobulin excretion in primary nephrotic children. Nephron 1996;74(2) :401 - 404.
  • 10Dandona P, Aljada A, Mohanty P, et. al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti - inflammatory effect? J Clin Endocrinol Metab 2001;8613257- 3265.

共引文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部